Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24604326)

1.

An enhanced butyrylcholinesterase method to measure organophosphorus nerve agent exposure in humans.

Pantazides BG, Watson CM, Carter MD, Crow BS, Perez JW, Blake TA, Thomas JD, Johnson RC.

Anal Bioanal Chem. 2014 Aug;406(21):5187-94. doi: 10.1007/s00216-014-7718-7. Epub 2014 Mar 7.

PMID:
24604326
2.

Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum.

Sporty JL, Lemire SW, Jakubowski EM, Renner JA, Evans RA, Williams RF, Schmidt JG, van der Schans MJ, Noort D, Johnson RC.

Anal Chem. 2010 Aug 1;82(15):6593-600. doi: 10.1021/ac101024z.

PMID:
20617824
3.

Novel dual-mode immunomagnetic method for studying reactivation of nerve agent-inhibited butyrylcholinesterase.

Abney CW, Knaack JL, Ali AA, Johnson RC.

Chem Res Toxicol. 2013 May 20;26(5):775-82. doi: 10.1021/tx4000717. Epub 2013 May 8.

PMID:
23656164
4.

A high-throughput diagnostic method for measuring human exposure to organophosphorus nerve agents.

Knaack JS, Zhou Y, Abney CW, Jacob JT, Prezioso SM, Hardy K, Lemire SW, Thomas J, Johnson RC.

Anal Chem. 2012 Nov 6;84(21):9470-7. doi: 10.1021/ac302301w. Epub 2012 Oct 19.

PMID:
23083472
5.

Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.

Carter MD, Crow BS, Pantazides BG, Watson CM, Thomas JD, Blake TA, Johnson RC.

Anal Chem. 2013 Nov 19;85(22):11106-11. doi: 10.1021/ac4029714. Epub 2013 Nov 8.

PMID:
24205842
6.

Verification of exposure to cholinesterase inhibitors: generic detection of OPCW Schedule 1 nerve agent adducts to human butyrylcholinesterase.

van der Schans MJ, Fidder A, van Oeveren D, Hulst AG, Noort D.

J Anal Toxicol. 2008 Jan-Feb;32(1):125-30.

7.

Quantification of nerve agent adducts with albumin in rat plasma using liquid chromatography-isotope dilution tandem mass spectrometry.

Bao Y, Liu Q, Chen J, Lin Y, Wu B, Xie J.

J Chromatogr A. 2012 Mar 16;1229:164-71. doi: 10.1016/j.chroma.2012.01.032. Epub 2012 Jan 18.

PMID:
22305360
8.

Quantitation of five organophosphorus nerve agent metabolites in serum using hydrophilic interaction liquid chromatography and tandem mass spectrometry.

Hamelin EI, Schulze ND, Shaner RL, Coleman RM, Lawrence RJ, Crow BS, Jakubowski EM, Johnson RC.

Anal Bioanal Chem. 2014 Aug;406(21):5195-202. doi: 10.1007/s00216-014-7702-2. Epub 2014 Mar 15.

PMID:
24633507
9.

Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.

Tsuge K, Seto Y.

J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 21;838(1):21-30. Epub 2006 Mar 29.

PMID:
16569519
10.

Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.

Barakat NH, Zheng X, Gilley CB, MacDonald M, Okolotowicz K, Cashman JR, Vyas S, Beck JM, Hadad CM, Zhang J.

Chem Res Toxicol. 2009 Oct;22(10):1669-79. doi: 10.1021/tx900096j.

11.

Modifications to the organophosphorus nerve agent-protein adduct refluoridation method for retrospective analysis of nerve agent exposures.

Holland KE, Solano MI, Johnson RC, Maggio VL, Barr JR.

J Anal Toxicol. 2008 Jan-Feb;32(1):116-24.

12.

Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.

Gilley C, MacDonald M, Nachon F, Schopfer LM, Zhang J, Cashman JR, Lockridge O.

Chem Res Toxicol. 2009 Oct;22(10):1680-8. doi: 10.1021/tx900090m.

13.

Profiling cholinesterase adduction: a high-throughput prioritization method for organophosphate exposure samples.

Carter MD, Crow BS, Pantazides BG, Watson CM, DeCastro BR, Thomas JD, Blake TA, Johnson RC.

J Biomol Screen. 2014 Feb;19(2):325-30. doi: 10.1177/1087057113497799. Epub 2013 Aug 16.

PMID:
23954929
14.

Magnetic electrochemical sensing platform for biomonitoring of exposure to organophosphorus pesticides and nerve agents based on simultaneous measurement of total enzyme amount and enzyme activity.

Du D, Wang J, Wang L, Lu D, Smith JN, Timchalk C, Lin Y.

Anal Chem. 2011 May 15;83(10):3770-7. doi: 10.1021/ac200217d. Epub 2011 Apr 21.

PMID:
21462919
15.

Enhanced stability of blood matrices using a dried sample spot assay to measure human butyrylcholinesterase activity and nerve agent adducts.

Perez JW, Pantazides BG, Watson CM, Thomas JD, Blake TA, Johnson RC.

Anal Chem. 2015 Jun 2;87(11):5723-9. doi: 10.1021/acs.analchem.5b00893. Epub 2015 May 20.

PMID:
25955132
16.

Quantification of nerve agent VX-butyrylcholinesterase adduct biomarker from an accidental exposure.

Solano MI, Thomas JD, Taylor JT, McGuire JM, Jakubowski EM, Thomson SA, Maggio VL, Holland KE, Smith JR, Capacio B, Woolfitt AR, Ashley DL, Barr JR.

J Anal Toxicol. 2008 Jan-Feb;32(1):68-72.

17.

Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.

Li H, Schopfer LM, Nachon F, Froment MT, Masson P, Lockridge O.

Toxicol Sci. 2007 Nov;100(1):136-45. Epub 2007 Aug 13.

18.

Comprehensive gas chromatography with Time of Flight MS and large volume introduction for the detection of fluoride-induced regenerated nerve agent in biological samples.

van der Meer JA, Trap HC, Noort D, van der Schans MJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 15;878(17-18):1320-5. doi: 10.1016/j.jchromb.2010.02.019. Epub 2010 Feb 21.

PMID:
20308021
19.

Liquid chromatography tandem mass spectrometry applied to quantitation of the organophosphorus nerve agent VX in microdialysates from blood probes.

Stubbs SJ, Read RW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2010 May 15;878(17-18):1253-6. doi: 10.1016/j.jchromb.2009.12.007. Epub 2009 Dec 5.

PMID:
20034857
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk